for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

European Medicines Agency: Benefits of AstraZeneca vaccine continue to outweigh the risks

AMSTERDAM, March 16 (Reuters) - Europe’s medicines watchdog on Tuesday said the benefits of AstraZeneca’s COVID-19 vaccine continue to outweigh the risks after several countries halted its use due to concerns about blood clots.

The EMA’s Executive Director Emer Cooke said the agency was carrying out a case-by-case evaluation of incidents and was expected to complete a review on Thursday. (Reporting by Anthony Deutsch; Editing by Catherine Evans)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up